eating disorders, part I: introduction to the series and a historical panorama. Adv Eat Disord. 2015 Jan 2; 3(1): 76-90.
843
Klein DA, Boudreau GS, Devlin MJ, Walsh BT. Artificial sweetener use among individuals with eating disorders. Int J Eat Disord. 2006 May 1; 39(4): 341-5.
844
Just T, Pau HW, Engel U, Hummel T. Cephalic phase insulin release in healthy humans after taste stimulation? Appetite. 2008 Nov 1; 51(3): 622-7.
845
Veedfald S, Plamboeck A, Deacon CF, Hartmann B, Knop FK, Vilsbøll T, et al. Cephalic phase secretion of insulin and other enteropancreatic hormones in humans. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2015 Oct 22; 310(1): G43-51.
846
Rozengurt E, Sternini C. Taste receptor signaling in the mammalian gut. Curr Opin Pharmacol. 2007 Dec 1; 7(6): 557-62.
847
Pepino MY. Metabolic effects of non-nutritive sweeteners. Physiol Behav. 2015 Dec 1; 152: 450-5.
848
Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, Stern MP. Fueling the obesity epidemic?: artificially sweetened beverage use and long-term weight gain. Obesity. 2008; 16(8): 1894-900.
849
Mattes RD, Popkin BM. Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms. Am J Clin Nutr. 2009 Jan 1; 89(1): 1-14.
850
Renwick AG, Molinary SV. Sweet-taste receptors, low-energy sweeteners, glucose absorption and insulin release. Br J Nutr. 2010 Nov;104(10): 1415-20.
851
Azad MB, Abou-Setta AM, Chauhan BF, Rabbani R, Lys J, Copstein L, et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. Can Med Assoc J. 2017 Jul 17; 189(28): E929-39.
852
Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. The Lancet. 1993 Apr 10; 341(8850): 938-41.
853
Gluckman PD, Hanson MA, Spencer HG. Predictive adaptive responses and human evolution. Trends Ecol Evol. 2005; 20(10): 527-33.
854
Gluckman PD, Hanson MA, Bateson P, Beedle AS, Law CM, Bhutta ZA, et al. Towards a new developmental synthesis: adaptive developmental plasticity and human disease. The Lancet. 2009 May 9; 373(9675): 1654-7.
855
Guerrero-Bosagna C. Transgenerational epigenetic inheritance: past exposures, future diseases. In: Rosenfeld CS, editor. The epigenome and developmental origins of health and disease [Internet]. Boston: Academic Press; 2016 [cited 2017 Dec 19]. pp. 425-37. Available from: https://www.sciencedirect.com/science/article/pii/B9780128013830000219.
856
Rosenfeld CS. Nutrition and epigenetics: evidence for multi- and transgenerational effects. In: Burdge G, Lillycrop K, editors. Nutrition, epigenetics and health. New Jersey: World Scientific; 2017, pp. 133-57.
857
Lea AJ, Altmann J, Alberts SC, Tung J. Developmental constraints in a wild primate. Am Nat. 2015 Jun 1; 185(6): 809-21.
858
Crespi BJ. Vicious circles: positive feedback in major evolutionary and ecological transitions. Trends Ecol Evol. 2004 Dec; 19(12): 627-33.
859
Nettle D, Bateson M. Adaptive developmental plasticity: what is it, how can we recognize it and when can it evolve? Proc Biol Sci. 2015 Aug 7; 282(1812): 20151005.
860
Nussbaum MC. The therapy of desire: theory and practice in Hellenistic ethics. Princeton (NJ): Princeton University Press; 1994.
861
Centers for Disease Control and Prevention. Fact sheets – Alcohol use and your health [Internet]. [cited 2018 Aug 16]. Available from: https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm.
862
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61(8): 807-18.
863
Substance Abuse and Mental Health Services Administration (SAMHSA). 2015 National Survey on Drug Use and Health (NSDUH). Table 5.6B – Substance use disorder in past year among persons aged 18 or older, by demographic characteristics: percentages, 2014 and 2015. Available at: https://www.samhsa.gov/data/sites/default/filesNSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.htm#tab5-6b.
864
Centers for Disease Control and Prevention. Tobacco-related mortality [Internet]. 2016 [cited 2017 Jul 17]. Available from: http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/tobacco_related_mortality.
865
Hill EM, Newlin DB. Evolutionary approaches to addiction. Addiction. 2002 Apr;97(4): 375-9.
866
Hyman SE. Addiction: a disease of learning and memory. FOCUS. 2007 Apr 1; 5(2): 220-8.
867
Nesse RM, Berridge KC. Psychoactive drug use in evolutionary perspective. Science. 1997; 278(5335): 63-6.
868
Dudley R. Evolutionary origins of human alcoholism in primate frugivory. Q Rev Biol. 2000; 75(1): 3-15.
869
Sullivan RJ, Hagen EH. Psychotropic substance-seeking: evolutionary pathology or adaptation? Addiction. 2002 Apr 1; 97(4): 389-400.
870
Chevallier J. The great medieval water myth. Les Leftovers [Internet]. 2013 [cited 2017 Dec 20]. Available from: https://leslefts.blogspot.com.au/2013/11/the-great-medieval-water-myth.html.
871
Dudley R. Ethanol, fruit ripening, and the historical origins of human alcoholism in primate frugivory. Integr Comp Biol. 2004 Aug; 44(4): 315-23.
872
Nesse RM. Evolution and addiction. Addiction. 2002 Apr;97(4): 470-1.
873
Hayden B, Canuel N, Shanse J. What was brewing in the Natufian?: an archaeological assessment of brewing technology in the Epipaleolithic. J Archaeol Method Theory. 2013 Mar 1; 20(1): 102-50.
874
Sullivan RJ, Hagen EH. Psychotropic substance-seeking: evolutionary pathology or adaptation? Addiction. 2002 Apr 1; 97(4): 389-400.
